Quantcast

Latest cell therapy Stories

2014-10-31 16:24:35

LA JOLLA, Calif., Oct. 31, 2014 /PRNewswire/ -- Human Longevity, Inc. (HLI), a biological data-driven human health technology and cell therapy company, today announced the addition of Barry Merriman, Ph.D., as Vice President of Global Technology Assessment and Paul Mola, M.S. as Head of Global Solutions. The two will work together in HLI's new Global Solutions Initiative to seek strategic business opportunities worldwide. http://photos.prnewswire.com/prnvar/20140304/LA76169LOGO...

2014-10-31 08:25:10

MENLO PARK, Calif., Oct. 31, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading biotechnology company in the emerging field of regenerative medicine, today announced that it will release third quarter financial and operating results on Monday, November 10, 2014 after the close of the U.S. financial markets. The Company will host a conference call via webcast on Monday, November 10, 2014 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss third quarter...

2014-10-30 23:05:16

Dr. Roy Schmidt and the staff of the Pain Specialist Center will host a free seminar and question-and-answer session about regenerative medicine on Tuesday, Nov. 11 at 6 p.m. Held at the clinic at 15 Stonebridge Blvd. in Jackson, the hour-long event will allow attendees to ask questions about stem cell therapy and platelet rich plasma therapy in a relaxed atmosphere. JACKSON, Tenn. (PRWEB) October 30, 2014 Dr. Roy Schmidt and the staff of the Pain Specialist Center will host a free...

2014-10-29 23:13:32

Backed by years of research, thousands of happy patients, and faster healing time is the latest in ethical stem cell treatments for foot pain offered at Adler Footcare of Greater New York. Stem cell therapy stimulates and produces healthy bones and cartilage to repair what’s been damaged in the foot and causing people debilitating foot pain. New York, New York (PRWEB) October 29, 2014 Stem cell therapy is the future of foot pain treatment. New York podiatrists at Adler Footcare are...

2014-10-29 08:34:57

First Ever Person with Type 1 Diabetes Receives Experimental Encapsulated Human Stem Cell-Derived Beta Cell Replacement Therapy NEW YORK, Oct. 29, 2014 /PRNewswire-USNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today that JDRF-funded partner, ViaCyte, Inc., a leading regenerative medicine company, has for the first time ever implanted a person with type 1 diabetes (T1D) with an experimental encapsulated cell...

2014-10-29 08:34:38

SAN DIEGO, Oct. 29, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, announced today that the first patient in its Phase 1/2 study was successfully implanted with VC-01(TM), its embryonic stem cell-derived islet replacement product candidate being developed as a treatment for type 1 diabetes. This Phase 1/2 clinical trial, designed to evaluate the VC-01 product candidate directly in patients with type 1 diabetes, is initially being conducted at UC...

2014-10-23 04:21:49

MONT-SAINT-GUIBERT, Belgium, October 23, 2014 /PRNewswire/ -- Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today the appointment of Dr. Warren Sherman as Chief Medical Officer, effective as of 1 November 2014. In this new role, Dr. Sherman will leverage his deep expertise in the cardiovascular and cell therapy fields to support the continued...

2014-10-20 20:25:44

LONDON, Oct.20, 2014 /PRNewswire/ -- Report Details Stem cell developers and producers - discover companies' R&D and revenue prospects Who are the top stem cell developers and producers? And what are their sales potentials? Visiongain's new report shows you their outlooks from 2014. There you discover therapies, sales results, trends, opportunities, and predictions of revenues. That way you find data and analysis on cellular technologies with potential to improve human...

2014-10-20 08:30:20

Provides for Immediate Release of Initial Grant Funds MENLO PARK, Calif., Oct. 20, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST) announced today that the Company has signed a Notice of Grant Award (NGA) with the California Institute of Regenerative Medicine (CIRM), effective October 1, 2014. The NGA provides for the immediate release of Clinical Development payments and the release of additional grant funds pursuant to the previously announced $14.3 million...

2014-10-16 08:30:41

RICHMOND, Calif., Oct. 16, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Company scientists and clinicians, as well as academic collaborators, were invited speakers at three major scientific meetings in Europe and the United States. Their presentations covered a number of therapeutic uses of Sangamo's novel zinc finger protein (ZFP) technology, but were primarily focused on reviewing the progress of the Company's ZFP Therapeutic(®) program in HIV/AIDS....


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related